High rates of undiagnosed and uncontrolled hypertension upon a screening campaign in rural Rwanda: a cross-sectional study.
High blood pressure
Hypertension
Rwanda
Screening
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
26 04 2022
26 04 2022
Historique:
received:
27
10
2021
accepted:
28
03
2022
entrez:
27
4
2022
pubmed:
28
4
2022
medline:
29
4
2022
Statut:
epublish
Résumé
Hypertension remains the major risk factor for cardiovascular diseases (CVDs) worldwide with a prevalence and mortality in low- and middle-income countries (LMICs) among the highest. The early detection of hypertension risk factors is a crucial pillar for CVD prevention. This cross-sectional study included 4284 subjects, mean age 46 ± 16SD, 56.4% females and mean BMI 26.6 ± 3.7 SD. Data were collected through a screening campaign in rural area of Kirehe District, Eastern of Rwanda, with the objective to characterize and examine the prevalence of elevated blood pressure (BP) and other CVD risk factors. An adapted tool from the World Health Organization STEPwise Approach was used for data collection. Elevated BP was defined as ≥ 140/90 mm/Hg and elevated blood glucose as blood glucose ≥ 100 mg/dL after a 6-h fast. Of the sampled population, 21.2% (n = 910) had an elevated BP at screening; BP was elevated among individuals not previously known to have HTN in 18.7% (n = 752). Among individuals with a prior diagnosis of HTN, 62.2% (n = 158 of 254) BP was uncontrolled. Age, weight, smoking, alcohol history and waist circumference were associated with BP in both univariate analyses and multivariate analysis. High rates of elevated BP identified through a health screening campaign in this Rwandan district were surprising given the rural characteristics of the district and relatively low population age. These data highlight the need to implement an adequate strategy for the prevention, diagnosis, and control of HTN that includes rural areas of Rwanda as part of a multicomponent strategy for CVD prevention.
Sections du résumé
BACKGROUND
Hypertension remains the major risk factor for cardiovascular diseases (CVDs) worldwide with a prevalence and mortality in low- and middle-income countries (LMICs) among the highest. The early detection of hypertension risk factors is a crucial pillar for CVD prevention.
DESIGN AND METHOD
This cross-sectional study included 4284 subjects, mean age 46 ± 16SD, 56.4% females and mean BMI 26.6 ± 3.7 SD. Data were collected through a screening campaign in rural area of Kirehe District, Eastern of Rwanda, with the objective to characterize and examine the prevalence of elevated blood pressure (BP) and other CVD risk factors. An adapted tool from the World Health Organization STEPwise Approach was used for data collection. Elevated BP was defined as ≥ 140/90 mm/Hg and elevated blood glucose as blood glucose ≥ 100 mg/dL after a 6-h fast.
RESULTS
Of the sampled population, 21.2% (n = 910) had an elevated BP at screening; BP was elevated among individuals not previously known to have HTN in 18.7% (n = 752). Among individuals with a prior diagnosis of HTN, 62.2% (n = 158 of 254) BP was uncontrolled. Age, weight, smoking, alcohol history and waist circumference were associated with BP in both univariate analyses and multivariate analysis.
CONCLUSION
High rates of elevated BP identified through a health screening campaign in this Rwandan district were surprising given the rural characteristics of the district and relatively low population age. These data highlight the need to implement an adequate strategy for the prevention, diagnosis, and control of HTN that includes rural areas of Rwanda as part of a multicomponent strategy for CVD prevention.
Identifiants
pubmed: 35473501
doi: 10.1186/s12872-022-02606-9
pii: 10.1186/s12872-022-02606-9
pmc: PMC9044706
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
197Informations de copyright
© 2022. The Author(s).
Références
Cardiovasc J Afr. 2015 Mar-Apr;26(2):82-5
pubmed: 25940121
BMC Cardiovasc Disord. 2021 Mar 4;21(1):123
pubmed: 33663387
BMC Cardiovasc Disord. 2019 Oct 26;19(1):236
pubmed: 31655560
BMC Public Health. 2013 Dec 09;13:1151
pubmed: 24321133
Int J Environ Res Public Health. 2021 Jan 29;18(3):
pubmed: 33572921
Diabetes Care. 2009 Jan;32 Suppl 1:S62-7
pubmed: 19118289
Diabet Med. 2012 Sep;29(9):e279-85
pubmed: 22510023
JAMA. 2021 Apr 27;325(16):1688
pubmed: 33904866
J Am Soc Hypertens. 2018 Apr;12(4):268-274
pubmed: 29452900
JAMA. 2013 Sep 4;310(9):959-68
pubmed: 24002282
Int J Gen Med. 2008 Nov 30;1:33-40
pubmed: 20428404
BMC Cardiovasc Disord. 2020 Sep 21;20(1):421
pubmed: 32957951
Health Commun. 2015;30(6):566-76
pubmed: 25010519
BMC Cardiovasc Disord. 2015 Jul 22;15:76
pubmed: 26197712
Biodemography Soc Biol. 2015;61(1):1-17
pubmed: 25879259
Lancet. 2008 May 3;371(9623):1513-8
pubmed: 18456100
Iran J Public Health. 2013 Aug;42(8):925-6
pubmed: 26056650
Circ Res. 2021 Apr 2;128(7):808-826
pubmed: 33793340
BMC Med. 2015 May 29;13:126
pubmed: 26021319
Circulation. 2018 Nov 27;138(22):2449-2451
pubmed: 30571350
Circulation. 2018 Oct 23;138(17):e484-e594
pubmed: 30354654
Indian J Med Res. 2006 May;123(5):657-64
pubmed: 16873908
BMC Public Health. 2017 Jul 10;18(1):2
pubmed: 28693458
Drug Alcohol Rev. 2021 Mar;40(3):402-419
pubmed: 33629786
PLoS One. 2019 Feb 8;14(2):e0210161
pubmed: 30735518
Glob Heart. 2015 Jun;10(2):111-22
pubmed: 26213298
J Hypertens. 2011 Jul;29(7):1243-52
pubmed: 21540748
PLoS One. 2014 Aug 04;9(8):e104300
pubmed: 25090232
Hypertension. 2021 Mar 3;77(3):806-812
pubmed: 33517681
BMC Cardiovasc Disord. 2019 Nov 20;19(1):258
pubmed: 31747878
Sci Rep. 2019 Jan 24;9(1):588
pubmed: 30679752
Glob Heart. 2019 Jun;14(2):135-141
pubmed: 31324367
Public Health. 2006 Jun;120(6):525-33
pubmed: 16684547
Rev Epidemiol Sante Publique. 2015 Dec;63(6):339-45
pubmed: 26586457
BMC Cardiovasc Disord. 2019 Oct 21;19(1):231
pubmed: 31638907
Cardiovasc J Afr. 2020 Jan/Feb 23;31(1):9-15
pubmed: 31781714